Zinc-Hydroxychloroquine Combination Effective in Some COVID-19 Patients: Study

Courtesy The Epoch Times

Treating COVID-19 patients with zinc in addition to hydroxychloroquine and azithromycin led to a higher rate of discharge from hospitals and a lower likelihood of dying, according to a new study.

Researchers at New York University’s School of Medicine reviewed records from roughly 900 patients with COVID-19, the disease caused by the CCP (Chinese Communist Party) virus.

About half received zinc sulfate in addition to hydroxychloroquine, a treatment typically used against malaria and lupus, and azithromycin, a common antibiotic. The other half received the two treatments without zinc.

Patients receiving the triple-drug treatment were 1.5 times more likely to recover enough to be discharged from hospitals and were 44 percent less likely to die, when compared to the other group.

“We found a statistically significant decrease in mortality among patients who received zinc as part of their treatment regimen. This is the first study, to our knowledge, that showed a clinical difference in patients with COVID-19 who received zinc,” Joseph Rahimian, one of the researchers, told The Epoch Times in an email.

READ MORE…